STOCK TITAN

If You Invested in 4FRONT VENTURES CORP (FFNTF)

Healthcare · Drug Manufacturers - Specialty & Generic · OTC
Looking for the current price? See the FFNTF quote & overview
$1,000 invested 1 Year Ago
$500
-50.0% price return -100.0% CAGR
-50.0% with dividends reinvested
Bought on Nov 3, 2025 at $0.0002 split-adjusted
$1,000 invested 5 Years Ago
$0
-100.0% price return -89.7% CAGR
-100.0% with dividends reinvested
Bought on Oct 27, 2021 at $0.99 split-adjusted

What $1,000 or $10,000 in FFNTF Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Mar 15, 2018
$1,000 $500 -50% $0 -100% — $0 -100%
$10,000 $5,000 -50% $1 -100% — $1 -100%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2025-11-11. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for FFNTF

$1,000 Investment Over Time

FFNTF vs S&P 500

Year-by-Year Returns

FFNTF annual performance
Year Start Price End Price Annual Return Cumulative
2018 $1.0870 $0.6760 -37.8% -37.8%
2019 $0.6760 $0.45 -33.4% -58.6%
2020 $0.45 $0.91 +102.2% -16.3%
2021 $0.91 $1.01 +11.0% -7.1%
2022 $1.01 $0.2335 -76.9% -78.5%
2023 $0.2335 $0.0993 -57.5% -90.9%
2024 $0.0993 $0.0135 -86.4% -98.8%
2025 $0.0135 $0.0001 -99.3% -100.0%

About 4FRONT VENTURES CORP

Healthcare · OTC

4Front Ventures Corp. (FFNTF) is described as a national, vertically integrated multi-state cannabis operator. The company is associated with the cannabis industry and is classified in the medicinal and botanical manufacturing space within the broader manufacturing sector. According to company disclosures, 4Front has focused on cultivation, production, and retail operations in the United States.

4Front states that it operates in Illinois and Massachusetts and has facilities in Washington. The company highlights experience in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. Over its history, 4Front reports that it has brought to market more than 20 cannabis brands and over 1,800 products, which it distributes through its fully owned and operated Mission-branded dispensaries and other retail outlets in its core markets.

The company traces its origins to its founding in 2011. Over time, it has emphasized low-cost cultivation and production methodologies and describes a track record in building and operating cannabis facilities. Its operations have included wholesale activities and retail channels in markets where cannabis is regulated at the state level.

Business model and operations

Based on the company’s own descriptions in its news releases, 4Front’s business model has combined cultivation and manufacturing of cannabis products with retail distribution. The company notes that its products are sold through Mission dispensaries and other retail outlets in its core markets. It also references wholesale activities, particularly in Massachusetts and Illinois, and has discussed cultivation and production facilities that support both wholesale and retail channels.

4Front has reported that it operates a large cultivation and production facility in Matteson, Illinois, which it has described as a key part of its expansion in that state. The company has also referred to facilities in Washington and operations in Massachusetts, indicating a multi-state footprint within the U.S. cannabis sector.

Recent corporate and legal developments

In 2025, 4Front announced a series of significant developments affecting its corporate and financial status. On May 22, 2025, all U.S. subsidiaries of 4Front filed for voluntary receivership in aid of liquidation under the laws of the Commonwealth of Massachusetts. The filings were made in the Business Litigation Session of the Superior Court for Suffolk County in case number 2584CV01405. The company stated that it intended to continue operating during the receivership process while pursuing an orderly sale of its subsidiaries’ assets.

On June 20, 2025, the court entered an order appointing Opus Consulting Partners, LLC, through its principal, as Receiver for the subsidiaries and their associated assets. The Receiver was granted authority to operate, manage, and pursue the sale of the subsidiaries with the stated goal of maximizing value for creditors and stakeholders. The Receiver was also authorized to engage a senior strategic consultant and advisor in connection with this process.

Separately, 4Front disclosed that it made an assignment into bankruptcy pursuant to the Canadian Bankruptcy and Insolvency Act. The company reported that B. Riley Farber was appointed as trustee in those Canadian bankruptcy proceedings. In another disclosure, 4Front noted that the Ontario Securities Commission issued a failure-to-file cease trade order against the company after it did not file audited annual financial statements and related disclosures for the year ended December 31, 2024, by the required deadline.

4Front has also indicated that, due to filing deficiencies and the receivership petition, it anticipates that its securities will ultimately be delisted from the Canadian Securities Exchange and the OTCQB. These developments mean that investors researching FFNTF should understand that the company is subject to receivership and bankruptcy processes and that trading in its securities has been restricted in certain jurisdictions.

Geographic footprint and activities

According to its public statements, 4Front’s core U.S. operations have been in Illinois and Massachusetts, with additional facilities in Washington. The company has described a 250,000 square foot cultivation and production facility in Matteson, Illinois, and has characterized Illinois as a key growth market. It has also referred to wholesale and retail activities in Massachusetts and to operations in Washington that have contributed to its revenue.

4Front’s Mission-branded dispensaries and retail outlets have been used to distribute its portfolio of cannabis brands and products in its core markets. The company has also discussed wholesale channels in Massachusetts and Illinois, indicating that its business has combined both direct-to-consumer retail and business-to-business wholesale components.

Status considerations for investors

Given the voluntary receivership of all U.S. subsidiaries, the Canadian bankruptcy proceedings, and the failure-to-file cease trade order issued by the Ontario Securities Commission, 4Front Ventures Corp. is in a distressed and restructuring context. The company has publicly stated that the receivership is intended to facilitate an orderly sale of its subsidiaries’ businesses or assets. It has also acknowledged that, as a result of these developments and filing deficiencies, its securities are expected to be delisted from the Canadian Securities Exchange and the OTCQB.

These disclosures mean that FFNTF represents a company undergoing court-supervised processes in multiple jurisdictions. Anyone examining FFNTF stock should review the latest court documents, regulatory orders, and company announcements to understand the implications for ownership interests, potential recoveries, and ongoing operations.

Market Cap
$0.0B
Current Price
$0.0001
View full FFNTF overview

Frequently Asked Questions

4FRONT VENTURES CORP investment returns

How much would $1,000 invested in 4FRONT VENTURES CORP be worth today?

If you invested $1,000 in 4FRONT VENTURES CORP (FFNTF) 5 years ago on 2021-10-27, your investment would be worth $0 as of 2025-11-11, a -100.0% price return without dividends, growing at a compounded rate of -89.7% per year (CAGR).

Has 4FRONT VENTURES CORP outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare FFNTF performance over available time periods.

What is 4FRONT VENTURES CORP's average annual return?

The compound annual growth rate (CAGR) of FFNTF’s share price over the past 5 years is -89.7%, without dividends. Individual years vary a great deal, and FFNTF’s best recent full year was 2020 (+102.2%) while the worst was 2024 (-86.4%).

For informational and educational purposes only, not investment advice.